Advertisement

Human Genetics

, Volume 116, Issue 6, pp 525–528 | Cite as

Matrix Gla protein and osteopontin genetic associations with coronary artery calcification and bone density: the CARDIA study

  • Brent C. TaylorEmail author
  • Pamela J. Schreiner
  • Terence M. Doherty
  • Myriam Fornage
  • J. Jeffrey Carr
  • Steve Sidney
Short Report

Abstract

A role for matrix proteins has previously been proposed in the pathogenesis of arterial calcification in the setting of atherosclerosis, and a link has been suggested between osteoporosis and arterial calcification. Our aim has been to investigate whether matrix Gla protein (MGP) T-138C, osteopontin (SPP1) T-443C, and Asp94Asp single nucleotide polymorphisms are associated with the development of arterial calcification and bone density. The individual effects of the MGP and SPP1 polymorphisms with coronary calcification are weak and not statistically significant. Bone mineral density differences at both the hip and spine do not vary statistically by genotype for any of the polymorphisms studied. Given the significant role of both MGP and SPP1 in arteriosclerosis, further research in higher risk, older populations are needed to determine fully the way in which MGP and SPP1 polymorphisms are associated with disease.

Keywords

Bone Mineral Density Coronary Artery Calcification Spine Bone Mineral Density Coronary Calcification Black Female 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgements

This work was partially supported by contracts N01-HC-48047, N01-HC-48048, N01-HC-48049, N01-HC-48050, and N01-HC-95095 from the National Heart, Lung and Blood Institute. T.M.D. was supported by a grant from Philip Morris USA.

References

  1. Canfield AE, Farrington C, Dziobon MD, Boot-Handford RP, Heagerty AM, Kumar SN, Roberts IS (2002) The involvement of matrix glycoproteins in vascular calcification and fibrosis: an immunohistochemical study. J Pathol 196:228–234Google Scholar
  2. Carr JJ, Nelson JC, Wong NA, McNitt-Gray M, Arad Y, Jacobs DR Jr, Sidney S, Bild DE, Williams OD, Detrano R (2005) Calcified coronary artery plaque measurement with cardiac CT in population-based studies: the standardized protocol of the Multi-Ethnic study of atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study. Radiology 234:35--43Google Scholar
  3. Dhore CR, Cleutjens JP, Lutgens E, Cleutjens KB, Geusens PP, Kitslaar PJ, Tordoir JH, Spronk HM, Vermeer C, Daemen MJ (2001) Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 21:1998–2003Google Scholar
  4. Doherty TM, Fitzpatrick LA, Inoue D, Qiao JH, Fishbein MC, Detrano RC, Shah PK, Rajavashisth TB (2004) Molecular, endocrine, and genetic mechanisms of arterial calcification. Endocr Rev 25:629–672Google Scholar
  5. Friedman GD, Cutter GR, Donahue RP, Hughes GH, Hulley SB, Jacobs DR Jr, Liu K, Savage PJ (1988) CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol 41:1105–1116Google Scholar
  6. Giacopelli F, Marciano R, Pistorio A, Catarsi P, Canini S, Karsenty G, Ravazzolo R (2004) Polymorphisms in the osteopontin promoter affect its transcriptional activity. Physiol Genomics 20:87–96Google Scholar
  7. Jono S, Ikari Y, Vermeer C, Dissel P, Hasegawa K, Shioi A, Taniwaki H, Kizu A, Nishizawa Y, Saito S (2004) Matrix Gla protein is associated with coronary artery calcification as assessed by electron-beam computed tomography. Thromb Haemost 91:790–794Google Scholar
  8. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G (1997) Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386:78–81CrossRefPubMedGoogle Scholar
  9. Speer MY, McKee MD, Guldberg RE, Liaw L, Yang HY, Tung E, Karsenty G, Giachelli CM (2002) Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo. J Exp Med 196:1047–1055CrossRefGoogle Scholar
  10. Taylor BC (2004) Genetic factors in bone density, fracture risk and arterial calcification: an epidemiological investigation using the study of osteoporotic fractures (SOF) and the coronary artery risk development in young adults (CARDIA) study. Dissertation Abstracts International 65:2899B (UMI no. AAT 3137149)Google Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  • Brent C. Taylor
    • 1
    • 2
    Email author
  • Pamela J. Schreiner
    • 2
  • Terence M. Doherty
    • 3
  • Myriam Fornage
    • 4
  • J. Jeffrey Carr
    • 5
  • Steve Sidney
    • 6
  1. 1.Center for Chronic Disease Outcomes ResearchVA Medical Center (152/2E)MinneapolisUSA
  2. 2.Division of Epidemiology, School of Public HealthUniversity of MinnesotaMinneapolisUSA
  3. 3.Burns and Allen Research Institute, Department of Medicine, Cedars-Sinai Medical CenterDavid Geffen School of Medicine at UCLALos AngelesUSA
  4. 4.Institute of Molecular MedicineUniversity of Texas Health Science CenterHoustonUSA
  5. 5.Department of RadiologyWake Forest UniversityWinston-SalemUSA
  6. 6.Division of ResearchKaiser Permanente Medical Care ProgramOaklandUSA

Personalised recommendations